Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in australia: A retrospective study. - Wikidata - wikimedia - TriplyDB

Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in australia: A retrospective study.

Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in australia: A retrospective study.

http://www.wikidata.org/entity/Q37672717

about

Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population.

P2860

Q36077322-0FABD461-8D60-47D6-98A3-489AB0E98299

P2860

Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in australia: A retrospective study.

http://www.wikidata.org/entity/Q37672717

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@en

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@nl

type

label

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@en

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@nl

prefLabel

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@en

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@nl

P1433

Q37672717-B3E6CD87-B07D-4EF2-94C0-23DF309276B3

P1476

Q37672717-20F1D576-30F1-4135-B126-D5A998667BB9

P2093

Q37672717-593CE8A8-6715-4564-A2C2-8F15FCEDF80A

Q37672717-8783D846-C061-46F9-9294-D357963184B5

Q37672717-98866697-D4EA-44CE-9F34-ED4DBAA2BABF

Q37672717-EEA8CE3B-2C23-4ACE-B5EA-74CCD6F76247

P2860

Q37672717-01FBCE79-FD0B-4B5A-A7C2-D29BA24D95C3

Q37672717-03759233-0BDC-4F25-9C7D-5697B78BE1E8

Q37672717-061391A3-5C52-4194-B68F-90BA79023303

Q37672717-09E2438E-1E24-48FB-89C6-083429A50F43

Q37672717-19EEC960-5B34-4194-A694-25A1672E55BE

Q37672717-24EDA548-7A7E-47D3-9392-5A7ACEF8BCCB

Q37672717-3319ACAC-2FEB-4B9E-86CF-16C0669F7FE3

Q37672717-374D5024-0873-48EB-976D-0EE6F2C6646E

Q37672717-42AA1641-98DA-4A2E-90A5-EED1FC3541D7

Q37672717-49AC6855-6D95-49B0-8890-286C487329ED

P304

Q37672717-0BFF8A8A-439F-4E90-9BDD-988F2BBC7F01

P31

Q37672717-FE4BE899-4CE3-4659-A756-814A6F5DF457

P356

Q37672717-1C50F27D-246F-4F82-8D66-C59F31DD8970

P433

Q37672717-4A63B0B0-F241-43A1-A311-0F9875231B20

P478

Q37672717-6D90B0E9-BD3C-4388-8FC4-A604EF78B9AB

P577

Q37672717-506DB0E4-6B36-46F9-BD68-597BFD4DF4E2

P5875

Q37672717-B474C095-17A4-4DF5-A067-4697FD3ADF8E

P698

Q37672717-2636AFC3-C7B0-49DA-AFE7-78E8BF61D6B3

P921

Q37672717-1E510F0B-DCB5-493B-AC42-F748360799E1

Q37672717-3CCE48DE-3377-4259-B760-9962FE0F76C4

Q37672717-766B1D70-5D81-42A9-B2B9-8596A68C5A7C

Q37672717-783A5D08-E051-4413-9237-1F6A82DB800D

Q37672717-B7C041B9-357D-429C-98B1-E20F57033776

P932

Q37672717-4E368D4D-C6BA-402E-BB22-5CA9138A8468

P356

J.CURTHERES.2008.12.001

P1433

Current Therapeutic Research

P1476

Pharmacotherapy for atrial fib ...... tralia: A retrospective study.

@en

P2093

Fiona White

http://www.w3.org/2001/XMLSchema#string

Lexin Wang

http://www.w3.org/2001/XMLSchema#string

Patrick Ball

http://www.w3.org/2001/XMLSchema#string

Shane Curran

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Antithrombotic therapy practices in US hospitals in an era of practice guidelines

Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice

Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?

Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention

The quality of health care delivered to adults in the United States

Why do patients with atrial fibrillation not receive warfarin?

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

P304

514-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CURTHERES.2008.12.001

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261294924

http://www.w3.org/2001/XMLSchema#string

P698

24692825

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

pharmacotherapy

atrial fibrillation

P932

3969916

http://www.w3.org/2001/XMLSchema#string